Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

PhRMA urges USTR to protect American innovators abroad

By Mark Grayson  |    February 10, 2017
Yesterday, PhRMA submitted comments for the 2017 Special 301 Report the Office of the U.S. Trade Representative (USTR) will publish in April. The comments highlight serious intellectual property...   Read More

Forced pharmaceutical localization fails to deliver

By Guest Contributor  |    June 15, 2016
  Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

Getting TTIP right, not rushed

By Jonathan Kimball  |    April 29, 2016
I had an opportunity to participate in the Stakeholders’ Event at the13th round of the Transatlantic Trade and Investment Partnership (TTIP) negotiations that took place in New York City earlier this...   Read More

ITIF report shows how Canada’s IP system is falling behind

By Mark Grayson  |    April 20, 2016
Over the last two and a half decades the world’s life expectancy has grown from 65 to 71 years. This life-changing advance is due in no small part to the creation of new drugs, therapies and...   Read More

Past free trade agreements provide valuable lessons for future success

By Jay Taylor  |    March 8, 2016
Last week, the Senate Committee on Finance held a hearing to discuss free trade agreement implementation and lessons learned from past agreements. The hearing focused on recent examples where...   Read More

Trade Facilitation and Enforcement Act will strengthen IP enforcement

By Mark Grayson  |    December 11, 2015
This week, a conference committee reported out H.R. 644, the Trade Facilitation and Trade Enforcement Act of 2015.  This bill will provide much needed tools for the Customs and Border Control...   Read More

Australia’s opportunity to lead the TPP forward

By Jay Taylor  |    September 18, 2015
New Australian Prime Minister Malcolm Turnbull is certainly going to have a busy autumn. As he works to form a new government, Australia must also strive to complete negotiations in the...   Read More

Week in Review: The Latest from PhRMA

By Priscilla VanderVeer  |    August 28, 2015
Developing New Medicines:  Innovative medicines offer hope to patients and bring value to the health care system, but developing these new treatments is a rigorous, lengthy and costly process, and...   Read More

Free Trade Agreements May Be Good For Your Health

By Mark Grayson  |    August 27, 2015
A new report by the Geneva Network titled “Trading for Health: Quantifying the Impact of Free Trade Agreements on Health Outcomes” recently called into question many claims being made by groups...   Read More

India’s IP Policies: Still Much Room for Improvement

By Mark Grayson  |    May 6, 2015
PhRMA Associate Vice President Amiee Aloi testified on May 5 before a U.S. International Trade Commission hearing examining the progress India is making to address relevant industrial trade and...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates